logo

For the Inventor, By the Inventor

Basking Ridge, NJ, United States of America

Qiang Xu

This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Agios Pharmaceuticals, Inc., Celgene Corporation. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qiang Xu. Retrieved from https://idiyas.com/inventor/qiang-xu-4bafs42q

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Basking Ridge, NJ (US) (2020)
  • Bernards, NJ (US) (2020)

Company Filing History:

goldMedal2 out of 99 
 
Agios Pharmaceuticals, Inc.
 patents
silverMedal2 out of 561 
 
Celgene Corporation
 patents
where one patent can have more than one assignee

Years Active: 2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents
1. 10695352 - Combination therapy for treating malignancies (2020-06-30),
2. 10653710 - Combination therapy for treating malignancies (2020-05-19),

Title: Qiang Xu: Innovator in Cancer Treatment

Introduction

Qiang Xu is a notable inventor based in Basking Ridge, NJ (US), recognized for his contributions to cancer treatment through innovative therapies. He holds 2 patents that focus on combination therapies for malignancies, particularly targeting specific genetic mutations.

Latest Patents

His latest patents include methods and compositions for treating cancers in patients carrying an IDH2 mutation. This involves a combination of an inhibitor of a mutant IDH2 enzyme and a DNA demethylating agent. Additionally, he has developed methods for treating hematological malignancies in patients with an IDH1 mutation, utilizing a specific compound alongside a DNA demethylating agent.

Career Highlights

Qiang Xu has worked with prominent companies in the pharmaceutical industry, including Celgene Corporation and Agios Pharmaceuticals, Inc. His work has significantly impacted the development of targeted cancer therapies, showcasing his expertise in the field.

Collaborations

Throughout his career, Qiang has collaborated with esteemed colleagues such as Vivek Saroj Kumar Chopra and Jorge DiMartino, contributing to advancements in cancer research and treatment.

Conclusion

Qiang Xu's innovative work in combination therapies for cancer treatment highlights his dedication to improving patient outcomes. His patents and collaborations reflect his significant role in the ongoing fight against malignancies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…